Reciprocal immuno-biological alterations occur during the co-culture of natural killer cells and adipose tissue-derived mesenchymal stromal cells

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Cytotechnology (Dordrecht)

• Publication date

  2019-01-10

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10616-019-00294-6PMID 30632032PMCID PMC6368507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal Cells

  2020cited by this paper
• Immunomodulatory effects of foreskin mesenchymal stromal cells on natural killer cells

  2018cited by this paper
• Immunological impact of Wharton’s Jelly mesenchymal stromal cells and natural killer cell co-culture

  2018cited by this paper
• Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation

  2018cited by this paper
• Immunohematology Mesenchymal Stromal Cell-based Therapy: From Research to Clinic

  2017cited by this paper
• Adipose stem cells for bone tissue repair.

  2017cited by this paper
• Tissue regeneration: The crosstalk between mesenchymal stem cells and immune response.

  2017cited by this paper
• Effect of Fibroblast-Like Cells of Mesenchymal Origin of Cytotoxic Activity of Lymphocytes against NK-Sensitive Target Cells

  2017cited by this paper
• Immunomodulatory effects of bone marrow versus adipose tissue‐derived mesenchymal stromal cells on NK cells: implications in the transplantation setting

  2016cited by this paper
• Human Mesenchymal Stromal Cells Attenuate Graft‐Versus‐Host Disease and Maintain Graft‐Versus‐Leukemia Activity Following Experimental Allogeneic Bone Marrow Transplantation

  2015cited by this paper
• Proteases in Apoptosis: Pathways, Protocols and Translational Advances

  2015cited by this paper
• TLR Ligands Stimulation Protects MSC from NK Killing

  2014cited by this paper
• Natural killer cell regulation - beyond the receptors

  2014cited by this paper
• Mesenchymal stem cell therapy and acute graft-versus-host disease: a review

  2014cited by this paper
• NK Cell Autoreactivity and Autoimmune Diseases

  2014cited by this paper
• Inhibition of mesenchymal stromal cells by pre-activated lymphocytes and their culture media

  2014cited by this paper
• Interaction with Mesenchymal Stem Cells Provokes Natural Killer Cells for Enhanced IL-12/IL-18-Induced Interferon-Gamma Secretion

  2014cited by this paper
• Isolation of Adipose-Derived Stromal Cells Without Enzymatic Treatment: Expansion, Phenotypical, and Functional Characterization

  2014cited by this paper
• Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT).

  2013cited by this paper
• IFN-γ Stimulated Human Umbilical-Tissue-Derived Cells Potently Suppress NK Activation and Resist NK-Mediated Cytotoxicity In Vitro

  2013cited by this paper
• TLR-induced PAI-2 expression suppresses IL-1β processing via increasing autophagy and NLRP3 degradation

  2013cited by this paper
• Clinical-Grade Mesenchymal Stromal Cells Produced Under Various Good Manufacturing Practice Processes Differ in Their Immunomodulatory Properties: Standardization of Immune Quality Controls

  2013cited by this paper
• Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL.

  2013cited by this paper
• Impact of different mesenchymal stromal cell types on T-cell activation, proliferation and migration.

  2013cited by this paper
• Macrophages modulate the viability and growth of human mesenchymal stem cells

  2013cited by this paper
• Tumour necrosis factor and cancer

  2013cited by this paper
• Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells

  2013cited by this paper
• Human Adipose-Derived Stem Cells Impair Natural Killer Cell Function and Exhibit Low Susceptibility to Natural Killer-Mediated Lysis

  2012cited by this paper
• Natural killer cell‐produced IFN‐γ and TNF‐α induce target cell cytolysis through up‐regulation of ICAM‐1

  2012cited by this paper
• Immunological Aspects of Allogeneic and Autologous Mesenchymal Stem Cell Therapies

  2011cited by this paper
• Human Mesenchymal Stem Cells Are Susceptible to Lysis by CD8+ T Cells and NK Cells

  2011cited by this paper
• Increased Lysis of Stem Cells but Not Their Differentiated Cells by Natural Killer Cells; De-Differentiation or Reprogramming Activates NK Cells

  2010cited by this paper
• The Effect of High-Altitude on Human Skeletal Muscle Energetics: 31P-MRS Results from the Caudwell Xtreme Everest Expedition

  2010cited by this paper
• Strategies to Rescue Mesenchymal Stem Cells (MSCs) and Dental Pulp Stem Cells (DPSCs) from NK Cell Mediated Cytotoxicity

  2010cited by this paper
• Control of granzymes by serpins

  2010cited by this paper
• Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6.

  2009cited by this paper
• Dichotomous role of interferon-gamma in allogeneic bone marrow transplant.

  2009cited by this paper
• Using human adipose tissue-derived mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease resembling acute hepatitis.

  2007cited by this paper
• Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

  2006cited by this paper
• Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells

  2006cited by this paper
• Role of Interferon-gamma in GVHD and GVL.

  2005cited by this paper
• Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

  2004cited by this paper
• The roles of IFN gamma in protection against tumor development and cancer immunoediting.

  2002cited by this paper

• Harnessing MSCs plasticity: mechanisms and determinants of bidirectional immune regulation in stem-cell-based immunotherapy

  2026cites this paper
• Mechanisms and potential of mesenchymal stem cell-derived exosomes for treating radiation-induced intestinal injury

  2025cites this paper
• Immunomodulatory Mechanism and Potential Application of Dental Pulp-Derived Stem Cells in Immune-Mediated Diseases

  2023cites this paper
• Complex interactions of cellular players in chronic Graft-versus-Host Disease

  2023cites this paper
• Comparative computational analysis to distinguish mesenchymal stem cells from fibroblasts

  2023cites this paper
• Application of hypoxia-mesenchymal stem cells in treatment of anaerobic bacterial wound infection: wound healing and infection recovery

  2023cites this paper
• Mesenchymal stem cells and natural killer cells interaction mechanisms and potential clinical applications

  2022cites this paper
• “Adipose-derived mesenchymal stem cell therapy for the management of female sexual dysfunction: Literature reviews and study design of a clinical trial”

  2022cites this paper
• The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings

  2021cites this paper
• The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal Cells

  2020cites this paper
• Immunomodulatory effects of foreskin mesenchymal stromal cells on natural killer cells

  2018cites this paper